Autophagy in Tumor Progression and Metastasis

自噬在肿瘤进展和转移中的作用

基本信息

  • 批准号:
    8311298
  • 负责人:
  • 金额:
    $ 32.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-13 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The importance of understanding the basis of tumor cell invasiveness, dissemination and dormancy in the periphery as factors leading to the outgrowth of overt metastases is highlighted by the emergence of recurrent and/or metastatic disease in breast cancer patients that were "successfully" treated years before. The overarching hypothesis of this proposal is that a process known as autophagy promotes some of the most aggressive and intractable features of metastatic breast cancer, namely increased tumor cell dissemination, increased tumor cell dormancy that can lead to disease recurrence and that autophagy promotes the "stem cell state", that is in turn linked to drug resistance. By genetically and chemically modulating the ability of the cell to induce autophagy, we will examine for the first time whether we can exploit the dependence of invasive cells on autophagy to eliminate them from the body and thereby prevent cancer from recurring or metastasizing effectively. Autophagy is a catabolic process activated in response to nutrient deprivation and/or hypoxia and is associated with cell cycle arrest, reduced growth, turnover of cellular constituents but also cell survival. There are three new concepts that are being proposed and tested: (1) autophagy plays differing roles in tumorigenesis depending on whether it is acting early in the process, where it likely acts to suppress tumor development, or late in the process, where we propose it acts to promote progression to invasiveness and metastasis. (Aim 1); (2) autophagy is required for tumor cell migration by promoting focal adhesion complex turnover and that the Ulk-1/FIP200 complex plays a dual role activating autophagy and inhibiting focal adhesion turnover that explains how autophagy and cell migration are coordinated (Aim 2); (3) autophagy is required for maintaining characteristics of tumor cells that are known as "stem-like". These properties include the ability to re-seed tumors when serially transplanted in vivo, to self-renew under such conditions and to give rise to "differentiated" tumor cells that lack such stem cell lik properties (Aim 3). We will also examine how autophagy promotes drug resistance of tumor cells. The proposed work is significant in putting forward a novel set of hypotheses to explain the role of autophagy in breast cancer metastasis and while each aim of the proposal is distinct in its own right, there is the possibility that by determining the extent to which tumor cell migration, invasiveness, dormancy and the stem cell nature of tumor propagating cells are dependent on autophagy, that we will make a major advance in understanding how these different features of advanced breast cancer are linked. Hence, it is predicted that our work will contribute to our understanding of how best to prevent tumor cell dissemination that is predicted to lead to reduced metastasis, limit disease recurrence and improved survival rates amongst breast cancer patients. In summary, this project will address several highly significant scientific questions and bring new perspective to the clinically relevant problem of breast cancer metastasis. PUBLIC HEALTH RELEVANCE: The importance of understanding the mechanistic basis of how tumor cells escape the primary tumor and spread to distant organs where they survive in a dormant or stem-like state before growing out to form overt metastases is highlighted by the emergence of recurrent and/or metastatic disease in breast cancer patients that were treated for their primary cancer years earlier. We will test the role of autophagy, an adaptive response to nutrient deprivation, in breast cancer metastasis with the goal of providing a novel understanding of the factors that determine how and when tumor cells become invasive, disseminate, remain dormant or grow out as overt metastases.
描述(由申请人提供):多年前“成功”治疗的乳腺癌患者出现复发和/或转移性疾病,这突出了理解肿瘤细胞侵袭、扩散和外周休眠作为导致显性转移生长的因素的基础的重要性。这一提议的首要假设是,一个被称为自噬的过程促进了转移性乳腺癌的一些最具侵略性和最棘手的特征,即增加肿瘤细胞扩散,增加肿瘤细胞休眠,可导致疾病复发,自噬促进“干细胞状态”,这反过来又与耐药性有关。通过基因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAY F MACLEOD其他文献

KAY F MACLEOD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAY F MACLEOD', 18)}}的其他基金

BNIP3 and BNIP3L (NIX) in lipid homeostasis and growth control in the liver
BNIP3 和 BNIP3L (NIX) 在肝脏脂质稳态和生长控制中的作用
  • 批准号:
    10752932
  • 财政年份:
    2016
  • 资助金额:
    $ 32.32万
  • 项目类别:
Autophagy in Tumor Progression and Metastasis
自噬在肿瘤进展和转移中的作用
  • 批准号:
    8874916
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Autophagy in Tumor Progression and Metastasis
自噬在肿瘤进展和转移中的作用
  • 批准号:
    8680183
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Autophagy in Tumor Progression and Metastasis
自噬在肿瘤进展和转移中的作用
  • 批准号:
    9097545
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Autophagy in Tumor Progression and Metastasis
自噬在肿瘤进展和转移中的作用
  • 批准号:
    8529473
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Functions of BNIP3 in Mammary Tumorigenesis
BNIP3 在乳腺肿瘤发生中的功能
  • 批准号:
    8204507
  • 财政年份:
    2009
  • 资助金额:
    $ 32.32万
  • 项目类别:
Functions of BNIP3 in Mammary Tumorigenesis
BNIP3 在乳腺肿瘤发生中的功能
  • 批准号:
    8010151
  • 财政年份:
    2009
  • 资助金额:
    $ 32.32万
  • 项目类别:
Functions of BNIP3 in Mammary Tumorigenesis
BNIP3 在乳腺肿瘤发生中的功能
  • 批准号:
    7762187
  • 财政年份:
    2009
  • 资助金额:
    $ 32.32万
  • 项目类别:
Functions of BNIP3 in Mammary Tumorigenesis
BNIP3 在乳腺肿瘤发生中的功能
  • 批准号:
    8408705
  • 财政年份:
    2009
  • 资助金额:
    $ 32.32万
  • 项目类别:
Functions of BNIP3 in Mammary Tumorigenesis
BNIP3 在乳腺肿瘤发生中的功能
  • 批准号:
    7663515
  • 财政年份:
    2009
  • 资助金额:
    $ 32.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了